VCYT — Veracyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Veracyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	173	179	216	289	413
Net Total Accounts Receivable
Net Total Receivables	41.5	44	40.4	46.5	44.7
Total Inventory
Prepaid Expenses
Total Current Assets	243	249	286	372	488
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.1	30.9	30.9	71.1	58.8
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,188	1,156	1,115	1,300	1,406
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	64.2	62.6	61.2	78.6	59.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	91.3	81.2	70.8	124	96.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,097	1,075	1,044	1,176	1,310
Total Liabilities & Shareholders' Equity	1,188	1,156	1,115	1,300	1,406
Total Common Shares Outstanding